BRAF and cancer: Attempts to overcome paradoxical RAF activation in RAS mutant cancer cells have included the development pan-RAFi that inhibit all RAF isoforms (ARAF, BRAF and CRAF)19 and ‘Paradox Breaker’ RAFis20.